Annual CFO
-$7.29 M
+$3.93 M+35.06%
31 December 2023
Summary:
Revelation Biosciences annual cash flow from operations is currently -$7.29 million, with the most recent change of +$3.93 million (+35.06%) on 31 December 2023. During the last 3 years, it has risen by +$3.80 million (+34.30%). REVBW annual CFO is now at all-time high.REVBW Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$9.26 M
-$6.78 M-273.46%
30 September 2024
Summary:
Revelation Biosciences quarterly cash flow from operations is currently -$9.26 million, with the most recent change of -$6.78 million (-273.46%) on 30 September 2024. Over the past year, it has dropped by -$7.25 million (-362.19%). REVBW quarterly CFO is now -439.24% below its all-time high of -$1.72 million, reached on 30 September 2023.REVBW Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$16.58 M
-$7.54 M-83.45%
30 September 2024
Summary:
Revelation Biosciences TTM cash flow from operations is currently -$16.58 million, with the most recent change of -$7.54 million (-83.45%) on 30 September 2024. Over the past year, it has dropped by -$12.86 million (-345.66%). REVBW TTM CFO is now -865.61% below its all-time high of -$1.72 million, reached on 30 September 2023.REVBW TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVBW Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -362.2% | -345.7% |
| 3 y3 years | +34.3% | -221.6% | -49.5% |
| 5 y5 years | - | - | - |
REVBW Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.1% | -439.2% | at low | -865.6% | at low |
| 5 y | 5 years | at high | +35.1% | -439.2% | at low | -865.6% | at low |
| alltime | all time | at high | +35.1% | -439.2% | at low | -865.6% | at low |
Revelation Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.26 M(+273.5%) | -$16.58 M(+83.4%) |
| June 2024 | - | -$2.48 M(-12.7%) | -$9.04 M(+37.8%) |
| Mar 2024 | - | -$2.84 M(+41.7%) | -$6.56 M(+76.3%) |
| Dec 2023 | -$7.29 M(-35.1%) | -$2.00 M(+16.7%) | -$3.72 M(+116.7%) |
| Sept 2023 | - | -$1.72 M(-53.7%) | -$1.72 M(-87.4%) |
| Dec 2022 | -$11.22 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$3.71 M(-23.2%) | -$13.65 M(+0.9%) |
| Mar 2022 | - | -$4.83 M(+67.8%) | -$13.54 M(+22.1%) |
| Dec 2021 | -$11.09 M | -$2.88 M(+28.8%) | -$11.09 M(+35.1%) |
| Sept 2021 | - | -$2.23 M(-37.8%) | -$8.21 M(+37.4%) |
| June 2021 | - | -$3.59 M(+50.9%) | -$5.98 M(+150.9%) |
| Mar 2021 | - | -$2.38 M | -$2.38 M |
FAQ
- What is Revelation Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Revelation Biosciences?
- What is Revelation Biosciences quarterly CFO year-on-year change?
- What is Revelation Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Revelation Biosciences?
- What is Revelation Biosciences TTM CFO year-on-year change?
What is Revelation Biosciences annual cash flow from operations?
The current annual CFO of REVBW is -$7.29 M
What is the all time high annual CFO for Revelation Biosciences?
Revelation Biosciences all-time high annual cash flow from operations is -$7.29 M
What is Revelation Biosciences quarterly cash flow from operations?
The current quarterly CFO of REVBW is -$9.26 M
What is the all time high quarterly CFO for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash flow from operations is -$1.72 M
What is Revelation Biosciences quarterly CFO year-on-year change?
Over the past year, REVBW quarterly cash flow from operations has changed by -$7.25 M (-362.19%)
What is Revelation Biosciences TTM cash flow from operations?
The current TTM CFO of REVBW is -$16.58 M
What is the all time high TTM CFO for Revelation Biosciences?
Revelation Biosciences all-time high TTM cash flow from operations is -$1.72 M
What is Revelation Biosciences TTM CFO year-on-year change?
Over the past year, REVBW TTM cash flow from operations has changed by -$12.86 M (-345.66%)